Press releases overview
UNIQA celebrates its anniversary in Serbia by providing free medical check-ups to clients with MedUNIQA health insurance
  • UNIQA marks its 15th anniversary in Serbia
  • To celebrate, the company will provide free medical check-ups to clients with individual MedUNIQA health insurance
  • From a new company on the market, UNIQA has grown into one of the most recognized brands in Serbia with more than 700,000 individual and corporate clients
  • The 15th anniversary was celebrated with another "Customers' Friend" gold medal for excellent customer service
Demand from investors for the bond was extremely high: issue was oversubscribed by a factor of 6.7
  • Second green subordinated bond successfully placed on capital market
  • UNIQA has already established sustainable investments totalling more than EUR 1 billion, taking account of EU regulations
  • Refinancing at attractive conditions: EUR 375 million of outstanding subordinated bonds redeemed

Publication of inside information pursuant to Article 17 MAR by euro adhoc with the aim of a Europe-wide dissemination. The issuer is responsible for the content.

THE INFORMATION CONTAINED HEREIN IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION TO OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN.

Publication of inside information pursuant to Article 17 MAR by euro adhoc with the aim of a Europe-wide dissemination. The issuer is responsible for the content.

THE INFORMATION CONTAINED HEREIN IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION TO OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN.

Publication of inside information pursuant to Article 17 MAR by euro adhoc with the aim of a Europe-wide dissemination. The issuer is responsible for the content.

THE INFORMATION CONTAINED HEREIN IS NOT INTENDED FOR PUBLICATION OR DISTRIBUTION TO OR WITHIN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN.

Earnings before taxes rise by around 40% to EUR 298.7 million
  • Premiums written grow by 18.0% to EUR 4,827.2 million
  • Combined ratio improves from 95.9% to 94.2%
  • Investment income up at EUR 417.8 million
  • Consolidated profit increases to EUR 235.8 million
  • Solvency II ratio still around 197%
  • Positive outlook confirmed for 2021 as a whole
Load more